Detalhe da pesquisa
1.
Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.
Br J Cancer
; 121(4): 318-324, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303643
2.
ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action.
Mol Cancer Ther
; 10(1): 126-37, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21177375
3.
Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines: investigations of the role of Fas in apoptosis due to cytokine starvation.
Cytokine
; 38(2): 74-83, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17604640
4.
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.
Bioorg Med Chem Lett
; 17(21): 5995-9, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17827005